An experimental six-strain Lyme vaccine has demonstrated more than 70% efficacy in preventing Lyme disease in people aged ...

Vital safety checks were not carried out on Covid vaccines before they were rolled out to millions, Germany’s pandemic ...

Lawyers for both sides in the federal lawsuit, brought by six medical organizations, are trying to understand the ...

Neither trial nor appeals court seems to understand the procedure for "willful misconduct" claims under the PREP Act, says lawyer for estate of college student who died from COVID vaccine.

A federal court has signaled that recent U.S. government actions altering vaccine recommendations and restructuring a key ...

Total revenues of €174.7 million in line with guidance, including €157.9 million in product sales Strong year-end cash position of €109.7 ...

Sachs Media is widening its reach in the health policy space with the debut of SachsHEALTH, a new division aimed at helping ...

Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and ...

There are currently no Lyme disease vaccines approved for people; a previous vaccine from 1998 was pulled from the market after reports of adverse events and poor sales, The Washington Post reported.

Pfizer said its experimental Lyme disease vaccine was more than 70% efficacious in reducing confirmed cases of the tickborne ...

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.